Add to Favourites
To login click here
SwRI has developed a unique technology using 3D drug screening software and machine learning to efficiently predict the DNA binding affinity and cancer cell toxicity of new DNA-targeting therapeutics. This advanced application has the potential to improve cancer treatment and combat other diseases.